Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

In Phispers this week, Pfizer won its high stakes battle with Novo Nordisk for the obesity-focused biotech Metsera. The deal i...

Impressions : 871

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

Impressions : 920

Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo's Rybelsus to reduce heart risk in diabetics

In this week’s Phispers, China’s Innovent Biologics signed one of the largest cross-border biotech deals in Asia. U...

Impressions : 989

Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

In this week’s Phispers, Novo Nordisk and Bristol Myers Squibb (BMS) struck multi-billion-dollar acquisitions to expand t...

Impressions : 734

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo's Rybelsus to reduce heart risk in diabetics

Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

Shanghai Henlius's Biologics Poherdy Receives Approval In US

Kura Oncology's Komzifti Receives Approval In US

Sandoz's Generics Carbidopa Receives Tentative Approval In US

Padagis's Generics Diazepam Receives Tentative Approval In US

Alembic's Generics Dexlansoprazole Receives Approval In US

Zydus's Generics Diroximel Fumarate Receives Approval In US

Gland's Generics Leucovorin Calcium Receives Approval In US

Laurus's Generics Sitagliptin Receives Tentative Approval In US

Macleods's Generics Vortioxetine HBr Recieves Approval In US

Cosette's Generics Ciprofloxacin HCl Receives Approval in US

FDA Issues Form 483 to Sanofi

Apotex Receives FDA Warning Letter

Taizhou Kangping Medical Scienc Receives FDA Warning Letter

Miers Laboratories Receives FDA Warning Letter

Fresenius Kabi Issues Voluntary Nationwide Recall of Famotidine

FDA Issues Form 483 to Alvotech

FDA Issues Form 483 to Medispray Lab

FDA Issues Form 483 to Laurus Lab

FDA Issues Form 483 to Alvotech Hf

FDA Issues Form 483 to Baxter Oncology

NIH Cuts Disrupted Hundreds Of Clinical Trials, Study Finds

FDA's Plan To Boost Biosims Could Stall At The Patent Office

Stoke, Biogen Publish 2-Year Dravet Data

SPARC Announces Consolidation Of R&D Laboratories And Facilities

Nuvalent Announces Public Offering Of Common Stock

Halda Therapeutics Announces Acquisition By Johnson & Johnson

Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy

Novo Sets New Self-Pay Prices For Wegovy, Ozempic

Bayer Opens Beijing Incubator, Names Initial Occupants

NRx Pharma Discloses Q3 2025 Financials & Corporate Update

Lupin Launches Long-Acting Risperidone In US

Zydus Lifesciences Receives USFDA Approval For Leuprolide Acetate

Zydus Gets FDA Nod For Diroximel Fumarate Capsules

Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release

Ingenus Pharma Launches First Generic Equivalent To Premarin

Amneal Receives U.S. FDA Approval For Iohexol Injection

Padagis Awarded New York Department of Health Naloxone Contract

Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics

Alembic Gets FDA Final Nod For Sumatriptan Injection USP

Alembic Announces USFDA Final Approval For Dasatinib Tablets

FDA's Plan To Boost Biosims Could Stall At The Patent Office

Nuvalent Announces Public Offering Of Common Stock

Halda Therapeutics Announces Acquisition By Johnson & Johnson

Genmab Sheds Another Clinical ADC From $1.8B Profoundbio Buy

Scribe Eyes Clinic As CRISPR Candidates Lower Lipids In Animals

JCR Pharma Launches Into Next 50 Years Of Innovation

Immatics Reveals Q3 2025 Financials And Business Progress

ADC Biotech Raises $120M To Seek Best-In-Class Formula

Enanta Pharma Reveals Fiscal Q4 & Full-Year 2025 Financials

Crescent Biopharma Announces Grants Of Inducement Awards

Import Price Floor On Cards For Critical Pharma Inputs

Akums Q2 PAT falls 35.8% on CDMO biz growth, declining API prices

Lupin Unit Expands CDMO Business With Oncology Block In Vizag

NPPA Revokes Decision Denying GSK's Antifungal Formulation

Farmson Unveils ?300 Crore Acetic Anhydride Unit In Vadodara

Indian API Firms Seek Protectionist Measures For Anti-Dumping

India Strategic Launchpad For Next Wave Of Obesity Care

Generic Drug And API Manufacturers Call For Onshoring Incentives

Lilly's Manufacturing Blitz Rolls on with $3B Plant in EU

Nxera Pharma Gets Partial Amendment for Quviviq Manufacturing

Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad

AIOCD & RDCA Support Regulatory Crackdown On MTP & Narcotic Drug

Medico Remedies Receives GMP Certificate From SMDC, In Ukraine

Aurobindo Pharma Receives 9 Observations From USFDA For Eugia

Regulator Tightens Quality Checks, Threatening Small Pharma Firms

Omnicell Secures URAC Certification For Health System Pharmacies

FDA Warns Companies For GMP And Unapproved Drug Violations

Fresenius, Sun, Teva & Others Launched Drug Recalls This Fall

Marksans Pharma's Goa Unit Clears FDA Inspection

CDSCO Orders Inspections Of MSME Pharma Units As Schedule M

NIH Cuts Disrupted Hundreds Of Clinical Trials, Study Finds

Neocis Unveils Next-Gen AI Robot for Dental Implants

Autonomix Medical Reveals Sustained Quality Of Life Gains